Despite low growth, undervalued Huntsman shares might be a good investment. However, the company's financial health is also key to consider. Its future outlook is possibly not fully reflected yet, offering a potentially attractive opportunity.
Huntsman's low P/S ratio is down to limited revenue growth predictions. Failure to increase its revenue might keep its share price low and possibly lower P/S levels.
Huntsman's stagnant business growth, marked by a declining ROCE and stable capital employed, dampens its investment appeal despite a robust 43% stock return over five years.
Gapping up In reaction to earnings/guidance: •$ボウレロ・コーポレーション(BOWL.US)$+3.4% Other news: •$インテリア・セラピューティクス(NTLA.US)$+10.8% (Interim Clinical Data for its Second Systemically Delivered Investigational CRISPR Candidate, NTLA-2002) •$ゴーゴー(GOGO.US)$+5% (Repurchases 1.5 million shares of common stock from BlackRock) •$ADCセラピューティクス(ADCT.US)$+2.9% (ADC Therapeutics and Swedish Orphan Biovitrum AB (BIOVF) confirms positive CHM...
Gainers: •$ナショナル・ビジョン・ホールディングス(EYE.US)$+13.8% (appointed to join S&P SmallCap 600) •$ブレイズ(BRZE.US)$+12.2% (In reaction to earnings/guidance) •$オラクル(ORCL.US)$+11.7% (In reaction to earnings/guidance) •$テラウルフ(WULF.US)$+7.5% (announced recent financing actions and near-term ramp of digital infrastructure) •$コンチネンタル・リソーシズ(CLR.US)$+7.5% (announces receipt of "take private" proposal from Hamm Family of $70/share) •...
Upgrades •$B&Gフーズ(BGS.US)$: Piper Sandler Upgrades to Neutral from Underweight - PT $23 (from $25) •$ノキア(NOK.US)$: Citigroup Upgrades to Buy from Neutral •$ネットアップ(NTAP.US)$: Deutsche Bank Upgrades to Buy from Hold - PT $84 (from $90) •$PBFエネジー(PBF.US)$: Wells Fargo Upgrades to Overweight from Equal Weight - PT $57 (from $30) •$USシリカ・ホールディングス(SLCA.US)$: Evercore ISI Upgrades to Outperform from In Line - PT $20 •$トムソン・ロイター(TRI.US)$: CIBC Up...
Gainers •$Anaplan(PLAN.US)$+28.2% (to be acquired by Thoma Bravo for $66.00 per share) •$ゲス(GES.US)$+5.04% (entered into an accelerated share repurchase agreement to repurchase $175 mln of its common stock) •$Membership Collective(MCG.US)$+2.8% (authorizes stock repurchase program to repurchase up to $50 mln of the Company's Class A common stock) •$Sorrento Therapeutics(SRNE.US)$+2.3% (reports promising results with a universal...
ハンツマンに関するコメント
コラムToday's Pre-Market Stock Movers: FDX, UBER, GE, NTLA and More
In reaction to earnings/guidance:
• $ボウレロ・コーポレーション(BOWL.US)$ +3.4%
Other news:
• $インテリア・セラピューティクス(NTLA.US)$ +10.8% (Interim Clinical Data for its Second Systemically Delivered Investigational CRISPR Candidate, NTLA-2002)
• $ゴーゴー(GOGO.US)$ +5% (Repurchases 1.5 million shares of common stock from BlackRock)
• $ADCセラピューティクス(ADCT.US)$ +2.9% (ADC Therapeutics and Swedish Orphan Biovitrum AB (BIOVF) confirms positive CHM...
コラムToday's pre-market stock movers: ORCL, CLR, NOK, GRPN and more
• $ナショナル・ビジョン・ホールディングス(EYE.US)$ +13.8% (appointed to join S&P SmallCap 600)
• $ブレイズ(BRZE.US)$ +12.2% (In reaction to earnings/guidance)
• $オラクル(ORCL.US)$ +11.7% (In reaction to earnings/guidance)
• $テラウルフ(WULF.US)$ +7.5% (announced recent financing actions and near-term ramp of digital infrastructure)
• $コンチネンタル・リソーシズ(CLR.US)$ +7.5% (announces receipt of "take private" proposal from Hamm Family of $70/share)
•...
コラムTop upgrades and downgrades on 6/14: NFLX, BBY, COIN, HPE and more
• $B&Gフーズ(BGS.US)$ : Piper Sandler Upgrades to Neutral from Underweight - PT $23 (from $25)
• $ノキア(NOK.US)$ : Citigroup Upgrades to Buy from Neutral
• $ネットアップ(NTAP.US)$ : Deutsche Bank Upgrades to Buy from Hold - PT $84 (from $90)
• $PBFエネジー(PBF.US)$ : Wells Fargo Upgrades to Overweight from Equal Weight - PT $57 (from $30)
• $USシリカ・ホールディングス(SLCA.US)$ : Evercore ISI Upgrades to Outperform from In Line - PT $20
• $トムソン・ロイター(TRI.US)$ : CIBC Up...
コラムToday's pre-market stock movers: TSLA, AAPL, POLY and more
• $Plantronics(POLY.US)$ +50% (to be acquired by HP Inc ($HPインク(HPQ.US)$) for $40.00 per share)
• $アクサム・セラピューティクス(AXSM.US)$ +21.6% (Jazz Pharma divests Sunosi to Axsome Therapeutics)
• $スターサージカル(STAA.US)$ +15.4% (receives FDA approval of EVO Visian Implantable Collamer Lenses)
• $Sarcos Technology & Robotics(STRC.US)$ +7.6% (announces that the Company has reached a definitive merger agreement to acquire Pittsburgh-base...
コラムToday's pre-market stock movers: PLAN, IMGN, NLSN and more
• $Anaplan(PLAN.US)$ +28.2% (to be acquired by Thoma Bravo for $66.00 per share)
• $ゲス(GES.US)$ +5.04% (entered into an accelerated share repurchase agreement to repurchase $175 mln of its common stock)
• $Membership Collective(MCG.US)$ +2.8% (authorizes stock repurchase program to repurchase up to $50 mln of the Company's Class A common stock)
• $Sorrento Therapeutics(SRNE.US)$ +2.3% (reports promising results with a universal...
コラムTop upgrades and downgrades on 3/21
• $エアープロダクツ・アンド・ケミカルズ(APD.US)$: JPMorgan Upgrades to Overweight from Neutral - PT $275
• $アソシエーテッド・バンコープ(ASB.US)$: Wells Fargo Upgrades to Overweight from Equal Weight - PT $28 (from $26)
• $アームストロング・ワールド・インダストリーズ(AWI.US)$: Jefferies Upgrades to Buy from Hold - PT $111 (from $101)
• $ブラックベリー(BB.US)$: RBC Capital Upgrades to Sector Perform from Underperform - PT $7
• $コマース・バンクシェアーズ(CBSH.US)$: Wells Fargo Upgrades to Equal Weight from...
Good fundamentals and can it break the sideway movement?
The P&L performance is good in Q1; But big negative WCR needs to be understood .
まだコメントはありません